Questions and answers on antithrombotic therapy: a companion document of the 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation†.

Jean-Philippe Collet, Marco Roffi, Christian Mueller, Marco Valgimigli, Carlo Patrono, Helmut Baumgartner, Oliver Gaemperli, Jose Luis Zamorano

European Heart Journal · 2015-08-29 · Guideline / consensus

Read at publisher · PubMed

Abstract

No abstract available.

Tags

Antithrombotics & thrombolytics · Acetylsalicylic acid · P2Y12 inhibitors · Heparin

Related articles

• [Treatment of ST segment elevation myocardial infarctions according to the guidelines]. (Herz, 2005)
• Management of acute coronary syndromes clinical guideline. (S Afr Med J, 2001)
• The effect of ASA, ticagrelor, and heparin in ST-segment myocardial infarction patients with prolonged transport times to primary percutaneous intervention. (Catheter Cardiovasc Interv, 2021)
• Current patterns of antithrombotic and revascularisation therapy in patients hospitalised for acute coronary syndromes. Data from the Polish subset of the EPICOR study. (Kardiol Pol, 2017)
• [Prehospital management of patients with acute coronary syndrome in Moscow. Data of the first Moscow "snapshot" register]. (Kardiologiia, 2013)
• Efficacy and safety of enoxaparin versus unfractionated heparin in patients with ST-segment elevation myocardial infarction also treated with clopidogrel. (J Am Coll Cardiol, 2007)